%0 Journal Article
%T Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents
%A Christopher D. Lao
%A Dirk Schadendorf
%A Jeffrey S. Weber
%A Michael Postow
%J Archive of "The Oncologist".
%D 2016
%R 10.1634/theoncologist.2016-0055
%K Programmed cell death 1 receptor
%K Nivolumab
%K Pembrolizumab
%K Drug-related side effects and adverse reactions
%K Melanoma
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061539/